⚕️ Compounded medications are not FDA-approved. Always consult a licensed provider.
Education 7 min read · May 2026

Is Tirzepatide the Same as Zepbound? (Yes, But Here's the Catch)

Market snapshot: Tirzepatide is the active molecule in both Zepbound (for weight loss) and Mounjaro (for type 2 diabetes). They are the same drug — made by the same company, using the same compound, in the same factory. The only differences are the FDA-approved indication, the label, and how your insurance treats them.

If you've searched "is tirzepatide the same as Zepbound," the short answer is yes. They're the same molecule. Here's the nuance that actually matters.

Same Molecule, Two Brand Names

Eli Lilly manufactures tirzepatide under two brand names:

ZepboundMounjaro
Active ingredientTirzepatideTirzepatide
ManufacturerEli LillyEli Lilly
FDA-approved forWeight loss + OSAType 2 diabetes
MechanismDual GIP/GLP-1 agonistDual GIP/GLP-1 agonist
AdministrationWeekly injectionWeekly injection
Dose range2.5mg – 15mg2.5mg – 15mg

This dual-branding strategy is common in pharma. The same approach exists for semaglutide: Wegovy (weight loss) and Ozempic (diabetes) are the same molecule under different labels.

Why It Matters: Insurance and Price

The brand name determines how your insurance treats the prescription:

If you have type 2 diabetes and your doctor prescribes Mounjaro, you may get better coverage than if the same doctor prescribed Zepbound for weight loss — even though they're the same drug.

What About Compounded Tirzepatide?

Compounded tirzepatide uses the same active molecule as both Zepbound and Mounjaro. The key differences are regulatory status (compounded is not FDA-approved), quality oversight (varies by pharmacy), and legal access (restricted since the FDA declared the shortage resolved in October 2024).

⚠️ Important: Compounded tirzepatide is neither 'Zepbound' nor 'Mounjaro' — those are trademarked brand names owned by Eli Lilly. Any provider calling their compounded product 'compounded Zepbound' is being misleading. The correct term is 'compounded tirzepatide.'

Current Pricing Landscape

OptionMonthly CostNotes
Zepbound (LillyDirect self-pay)$299 (2.5mg) – $449 (7.5mg+)Must refill within 45 days at higher doses
Zepbound (insurance + savings card)As low as $25/moCommercial insurance only
Zepbound KwikPen (Medicare Bridge)$50/moStarting July 1, 2026
Mounjaro (for T2D, insured)Varies by planOften better coverage than Zepbound
GobyMeds (compounded tirz)$133/moDirect affiliate. Code x7X72r saves $25
Yucca Health (compounded tirz)$258/mo (6-mo plan)Requires commitment
SkinnyRx (compounded)From $249/moInjectable, sublingual, or tablet

The molecule is identical across all options. Your decision should be based on: (1) insurance coverage and out-of-pocket cost, (2) regulatory comfort level with compounded vs. brand, and (3) whether you have a comorbidity (T2D, OSA) that unlocks better coverage under a specific brand indication.

When Will Generic Tirzepatide Be Available?

Not anytime soon. Eli Lilly's patent protection on tirzepatide extends past 2036. There is no generic tirzepatide expected in the US before then. This is different from liraglutide (Saxenda), which went generic in August 2025.

Compare Verified Providers

Most Formats — $500 CPA

SkinnyRx

From $249/mo tirzepatide

Injectable, sublingual, and tablet formats. Three delivery methods.

Learn More Paid link

Compounded medications are not FDA-approved.

Best Tirz Price

Yucca Health

$258/mo (6-mo plan)

Deepest tirzepatide discount. Both sema and tirz.

Learn More Paid link

Compounded medications are not FDA-approved.

Sema Pick

Embody

$149 first / $299 refills

Injectable semaglutide — if cost or availability steers you to sema.

Learn More Paid link

Compounded medications are not FDA-approved.

Best Value

GobyMeds

$133/mo tirzepatide

Lowest tirz price. LegitScript, 503A+503B. Code x7X72r saves $25.

Learn More Paid link

Compounded medications are not FDA-approved.

Compare All GLP-1 Providers Side by Side

See pricing, medications, and ratings for verified telehealth providers.

View Provider Comparison →

Sources

  1. Eli Lilly: Zepbound and Mounjaro prescribing information.
  2. FDA: Zepbound approval for OSA, December 2024.
  3. LillyDirect: Self-pay pricing, verified May 2026.
  4. Provider websites: compounded tirzepatide pricing, verified May 2026.

Affiliate Disclosure: Some links on this page are paid affiliate links. If you sign up through them, we may earn a commission at no extra cost to you. This does not influence our editorial content or sourcing.

Medical Disclaimer: This content is for informational purposes only and is not medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

FDA Notice: Compounded medications referenced in this article are not FDA-approved. Only brand-name GLP-1 medications (Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo) carry FDA approval for their indicated uses.

Related Articles